The use of recombinant factor VIIa in children with inherited platelet function disorders.
Almeida AM, Khair K, Hann I, Liesner R
Br J Haematol 2003;121(3):477-481.
Review by Aldouri M
The interaction between platelets and factor VII/VIIa.
Lau HKF
Transfus Apheresis Sci 2003;28(3):279-283.
Review by Aldouri M
Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
Allen GA, Hoffman M, Roberts HR, Monroe DM
Can J Anaesth 2002;49(10):S7-S14.
Review by Aldouri M
Possible role of recombinant activated factor VII (RFVIIa) in the control of hemorrhage associated with massive trauma.
Martinowitz U, Kenet G, Lubetski A, Luboshitz J, Segal E
Can J Anaesth 2002;49(10):S15-S20.
Review by
A novel hemostatic agent: the potential role of recombinant activated factor VII (RFVIIa) in anesthetic practice.
Murkin JM
Can J Anaesth 2002;49(10):S21-S26.
Review by Aldouri M
New approach to management of life-threatening bleeding in a Jehovah’s Witness.
Hickey R
Crit Care Med 2002;30(8):1930-1931.
Review by Hardy JF
Severe anemia after gastrointestinal hemorrhage in a Jehovah’s Witness: new treatment strategies.
Gannon CJ, Napolitano LM
Crit Care Med 2002;30(8):1893-1895.
Review by Hardy JF**
Transfusion-related acute lung injury during plasma exchange: Suspecting the unsuspected.
Askari S, Nollet K, Debol SM, Brunstein CG, Eastlund T
J Clin Apheresis 2002;17(2):93-96.
Review by Kretschmer V***; Contreras M***
Acquired factor VII deficiency in hematopoietic stem cell transplant recipients.
Toor AA, Slungaard A, Hedner U, Weisdorf DJ, Key NS
Bone Marrow Transplant 2002;29(5):403-408.
Review by Aldouri M
Successful use of recombinant factor VIIa for hemostasis during total knee replacement in a severe hemophiliac with high-titer factor VIII inhibitor.
Carr ME, Loughran TP, Cardea JA, Smith WK, Kuhn JG, Dottore MV
Int J Hematol 2002;75(1):95-99.
Review by
Use of recombinant factor VIIa in hereditary bleeding disorders.
Poon MC
Curr Opin Hematol 2001;8(5):312-318.
Review by M. Aldouri
New products for managing inhibitors to coagulation factors: a focus on recombinant factor VIIa concentrate.
Kessler CM
Curr Opin Hematol 2000;7(6):408-413.
Review by M. Aldouri
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659